Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy

This case report describes the re-administration of abatacept to successfully reduce the articularsymptoms of a patient with rheumatoid arthritisduring the intensive phase of anti-tuberculous therapy. A 75-year-old man developed active pulmonary tuberculosis during the administration of abatacept fo...

Full description

Bibliographic Details
Main Authors: Hironori Kawamoto, M.D., Jin Takasaki, Satoru Ishii, Manabu Suzuki, Eriko Morino, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Haruhito Sugiyama
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007117300631
_version_ 1819273981840064512
author Hironori Kawamoto, M.D.
Jin Takasaki
Satoru Ishii
Manabu Suzuki
Eriko Morino
Go Naka
Motoyasu Iikura
Shinyu Izumi
Yuichiro Takeda
Haruhito Sugiyama
author_facet Hironori Kawamoto, M.D.
Jin Takasaki
Satoru Ishii
Manabu Suzuki
Eriko Morino
Go Naka
Motoyasu Iikura
Shinyu Izumi
Yuichiro Takeda
Haruhito Sugiyama
author_sort Hironori Kawamoto, M.D.
collection DOAJ
description This case report describes the re-administration of abatacept to successfully reduce the articularsymptoms of a patient with rheumatoid arthritisduring the intensive phase of anti-tuberculous therapy. A 75-year-old man developed active pulmonary tuberculosis during the administration of abatacept for rheumatoid arthritis. The patient experienced a paradoxical reaction and exacerbation of rheumatoid arthritis that caused us to discontinue the abatacept. Later re-administration of abatacept along with anti-tuberculosis treatment led to well-controlled rheumatoid arthritis without exacerbation of the tuberculosis. This case shows that re-administration of abatacept may be much safer than TNF inhibitor to treat patients who are infected with mycobacteria during thetreatment of immunological diseases such asrheumatoid arthritiswith biological agents.
first_indexed 2024-12-23T23:01:10Z
format Article
id doaj.art-2782924252f84758b38339fe7eb8f052
institution Directory Open Access Journal
issn 2213-0071
language English
last_indexed 2024-12-23T23:01:10Z
publishDate 2017-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj.art-2782924252f84758b38339fe7eb8f0522022-12-21T17:26:54ZengElsevierRespiratory Medicine Case Reports2213-00712017-01-0121C14715010.1016/j.rmcr.2017.04.013Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapyHironori Kawamoto, M.D.0Jin Takasaki1Satoru Ishii2Manabu Suzuki3Eriko Morino4Go Naka5Motoyasu Iikura6Shinyu Izumi7Yuichiro Takeda8Haruhito Sugiyama9Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Tokyo, JapanDivision of Respiratory Diseases, Department of Internal Medicine, National Center for Global Health and Medicine, Tokyo, JapanThis case report describes the re-administration of abatacept to successfully reduce the articularsymptoms of a patient with rheumatoid arthritisduring the intensive phase of anti-tuberculous therapy. A 75-year-old man developed active pulmonary tuberculosis during the administration of abatacept for rheumatoid arthritis. The patient experienced a paradoxical reaction and exacerbation of rheumatoid arthritis that caused us to discontinue the abatacept. Later re-administration of abatacept along with anti-tuberculosis treatment led to well-controlled rheumatoid arthritis without exacerbation of the tuberculosis. This case shows that re-administration of abatacept may be much safer than TNF inhibitor to treat patients who are infected with mycobacteria during thetreatment of immunological diseases such asrheumatoid arthritiswith biological agents.http://www.sciencedirect.com/science/article/pii/S2213007117300631TuberculosisBiological agentAbataceptParadoxical reactionRheumatoid arthritis
spellingShingle Hironori Kawamoto, M.D.
Jin Takasaki
Satoru Ishii
Manabu Suzuki
Eriko Morino
Go Naka
Motoyasu Iikura
Shinyu Izumi
Yuichiro Takeda
Haruhito Sugiyama
Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy
Respiratory Medicine Case Reports
Tuberculosis
Biological agent
Abatacept
Paradoxical reaction
Rheumatoid arthritis
title Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy
title_full Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy
title_fullStr Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy
title_full_unstemmed Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy
title_short Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy
title_sort re administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti tuberculous therapy
topic Tuberculosis
Biological agent
Abatacept
Paradoxical reaction
Rheumatoid arthritis
url http://www.sciencedirect.com/science/article/pii/S2213007117300631
work_keys_str_mv AT hironorikawamotomd readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT jintakasaki readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT satoruishii readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT manabusuzuki readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT erikomorino readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT gonaka readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT motoyasuiikura readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT shinyuizumi readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT yuichirotakeda readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy
AT haruhitosugiyama readministrationofabataceptforthecontrolofarticularsymptomsofrheumatoidarthritisduringantituberculoustherapy